5392682026-01-012026-03-315392682026-03-315392682025-03-315392682025-04-012026-03-315392682026-01-012026-03-31in-capmkt:OtherExpenses1Member5392682026-01-012026-03-31in-capmkt:OtherExpenses2Member5392682025-04-012026-03-31in-capmkt:OtherExpenses1Member5392682025-04-012026-03-31in-capmkt:OtherExpenses2Member5392682026-03-31OtherNoncurrentFinancialAssetsDomain15392682026-03-31OtherNoncurrentFinancialAssetsDomain25392682026-03-31OtherNoncurrentAssetsDomain15392682026-03-31OtherNoncurrentAssetsDomain25392682026-03-31OtherCurrentFinancialAssetsDomain15392682026-03-31OtherCurrentFinancialAssetsDomain25392682026-03-31OtherCurrentAssetsDomain15392682026-03-31OtherNoncurrentFinancialLiabilitiesDomain15392682026-03-31OtherNoncurrentFinancialLiabilitiesDomain25392682026-03-31OtherNoncurrentFinancialLiabilitiesDomain35392682026-03-31OtherNoncurrentLiabilitiesDomain15392682026-03-31OtherCurrentFinancialLiabilitiesDomain15392682026-03-31OtherCurrentFinancialLiabilitiesDomain25392682026-03-31OtherCurrentFinancialLiabilitiesDomain35392682026-03-31OtherCurrentLiabilitiesDomain15392682026-01-012026-03-31ItemsThatWillNotBeReclassifiedToProfitAndLoss15392682025-04-012026-03-31ItemsThatWillNotBeReclassifiedToProfitAndLoss15392682026-01-012026-03-31ItemsThatWillBeReclassifiedToProfitAndLoss15392682025-04-012026-03-31ItemsThatWillBeReclassifiedToProfitAndLoss15392682026-01-012026-03-31RelatedPartyTransactionDomain15392682025-12-31RelatedPartyTransactionDomain15392682026-03-31RelatedPartyTransactionDomain15392682026-01-012026-03-31RelatedPartyTransactionDomain25392682025-12-31RelatedPartyTransactionDomain25392682026-03-31RelatedPartyTransactionDomain25392682026-01-012026-03-31RelatedPartyTransactionDomain35392682025-12-31RelatedPartyTransactionDomain35392682026-03-31RelatedPartyTransactionDomain35392682026-01-012026-03-31RelatedPartyTransactionDomain45392682025-12-31RelatedPartyTransactionDomain45392682026-03-31RelatedPartyTransactionDomain45392682026-01-012026-03-31RelatedPartyTransactionDomain55392682025-12-31RelatedPartyTransactionDomain55392682026-03-31RelatedPartyTransactionDomain55392682026-01-012026-03-31RelatedPartyTransactionDomain65392682025-12-31RelatedPartyTransactionDomain65392682026-03-31RelatedPartyTransactionDomain65392682026-01-012026-03-31RelatedPartyTransactionDomain75392682025-12-31RelatedPartyTransactionDomain75392682026-03-31RelatedPartyTransactionDomain75392682026-01-012026-03-31RelatedPartyTransactionDomain85392682025-12-31RelatedPartyTransactionDomain85392682026-03-31RelatedPartyTransactionDomain85392682026-01-012026-03-31RelatedPartyTransactionDomain95392682025-12-31RelatedPartyTransactionDomain95392682026-03-31RelatedPartyTransactionDomain95392682026-01-012026-03-31RelatedPartyTransactionDomain105392682025-12-31RelatedPartyTransactionDomain105392682026-03-31RelatedPartyTransactionDomain105392682026-01-012026-03-31RelatedPartyTransactionDomain115392682025-12-31RelatedPartyTransactionDomain115392682026-03-31RelatedPartyTransactionDomain115392682026-01-012026-03-31RelatedPartyTransactionDomain125392682025-12-31RelatedPartyTransactionDomain125392682026-03-31RelatedPartyTransactionDomain125392682026-01-012026-03-31RelatedPartyTransactionDomain135392682025-12-31RelatedPartyTransactionDomain135392682026-03-31RelatedPartyTransactionDomain135392682026-01-012026-03-31RelatedPartyTransactionDomain145392682025-12-31RelatedPartyTransactionDomain145392682026-03-31RelatedPartyTransactionDomain145392682026-01-012026-03-31RelatedPartyTransactionDomain155392682025-12-31RelatedPartyTransactionDomain155392682026-03-31RelatedPartyTransactionDomain155392682026-01-012026-03-31RelatedPartyTransactionDomain165392682025-12-31RelatedPartyTransactionDomain165392682026-03-31RelatedPartyTransactionDomain165392682026-01-012026-03-31RelatedPartyTransactionDomain175392682025-12-31RelatedPartyTransactionDomain175392682026-03-31RelatedPartyTransactionDomain175392682026-01-012026-03-31RelatedPartyTransactionDomain185392682025-12-31RelatedPartyTransactionDomain185392682026-03-31RelatedPartyTransactionDomain185392682026-01-012026-03-31RelatedPartyTransactionDomain195392682025-12-31RelatedPartyTransactionDomain195392682026-03-31RelatedPartyTransactionDomain195392682026-01-012026-03-31RelatedPartyTransactionDomain205392682025-12-31RelatedPartyTransactionDomain205392682026-03-31RelatedPartyTransactionDomain205392682026-01-012026-03-31RelatedPartyTransactionDomain215392682025-12-31RelatedPartyTransactionDomain215392682026-03-31RelatedPartyTransactionDomain215392682026-01-012026-03-31RelatedPartyTransactionDomain225392682025-12-31RelatedPartyTransactionDomain225392682026-03-31RelatedPartyTransactionDomain225392682026-01-012026-03-31RelatedPartyTransactionDomain235392682025-12-31RelatedPartyTransactionDomain235392682026-03-31RelatedPartyTransactionDomain235392682026-01-012026-03-31RelatedPartyTransactionDomain245392682025-12-31RelatedPartyTransactionDomain245392682026-03-31RelatedPartyTransactionDomain245392682026-01-012026-03-31RelatedPartyTransactionDomain255392682025-12-31RelatedPartyTransactionDomain255392682026-03-31RelatedPartyTransactionDomain255392682026-01-012026-03-31RelatedPartyTransactionDomain265392682025-12-31RelatedPartyTransactionDomain265392682026-03-31RelatedPartyTransactionDomain265392682026-01-012026-03-31RelatedPartyTransactionDomain275392682025-12-31RelatedPartyTransactionDomain275392682026-03-31RelatedPartyTransactionDomain275392682026-01-012026-03-31RelatedPartyTransactionDomain285392682025-12-31RelatedPartyTransactionDomain285392682026-03-31RelatedPartyTransactionDomain285392682026-01-012026-03-31RelatedPartyTransactionDomain295392682025-12-31RelatedPartyTransactionDomain295392682026-03-31RelatedPartyTransactionDomain295392682026-01-012026-03-31RelatedPartyTransactionDomain305392682025-12-31RelatedPartyTransactionDomain305392682026-03-31RelatedPartyTransactionDomain305392682026-01-012026-03-31RelatedPartyTransactionDomain315392682025-12-31RelatedPartyTransactionDomain315392682026-03-31RelatedPartyTransactionDomain315392682026-01-012026-03-31RelatedPartyTransactionDomain325392682025-12-31RelatedPartyTransactionDomain325392682026-03-31RelatedPartyTransactionDomain325392682026-01-012026-03-31RelatedPartyTransactionDomain335392682025-12-31RelatedPartyTransactionDomain335392682026-03-31RelatedPartyTransactionDomain335392682026-01-012026-03-31RelatedPartyTransactionDomain345392682025-12-31RelatedPartyTransactionDomain345392682026-03-31RelatedPartyTransactionDomain345392682026-01-012026-03-31RelatedPartyTransactionDomain355392682025-12-31RelatedPartyTransactionDomain355392682026-03-31RelatedPartyTransactionDomain355392682026-01-012026-03-31RelatedPartyTransactionDomain365392682025-12-31RelatedPartyTransactionDomain365392682026-03-31RelatedPartyTransactionDomain365392682026-01-012026-03-31RelatedPartyTransactionDomain375392682025-12-31RelatedPartyTransactionDomain375392682026-03-31RelatedPartyTransactionDomain375392682026-01-012026-03-31RelatedPartyTransactionDomain385392682025-12-31RelatedPartyTransactionDomain385392682026-03-31RelatedPartyTransactionDomain385392682026-01-012026-03-31RelatedPartyTransactionDomain395392682025-12-31RelatedPartyTransactionDomain395392682026-03-31RelatedPartyTransactionDomain395392682026-01-012026-03-31RelatedPartyTransactionDomain405392682025-12-31RelatedPartyTransactionDomain405392682026-03-31RelatedPartyTransactionDomain405392682026-01-012026-03-31RelatedPartyTransactionDomain415392682025-12-31RelatedPartyTransactionDomain415392682026-03-31RelatedPartyTransactionDomain415392682026-01-012026-03-31RelatedPartyTransactionDomain425392682025-12-31RelatedPartyTransactionDomain425392682026-03-31RelatedPartyTransactionDomain425392682026-01-012026-03-31RelatedPartyTransactionDomain435392682025-12-31RelatedPartyTransactionDomain435392682026-03-31RelatedPartyTransactionDomain435392682026-01-012026-03-31RelatedPartyTransactionDomain445392682025-12-31RelatedPartyTransactionDomain445392682026-03-31RelatedPartyTransactionDomain445392682026-01-012026-03-31RelatedPartyTransactionDomain455392682025-12-31RelatedPartyTransactionDomain455392682026-03-31RelatedPartyTransactionDomain455392682026-01-012026-03-31RelatedPartyTransactionDomain465392682025-12-31RelatedPartyTransactionDomain465392682026-03-31RelatedPartyTransactionDomain465392682026-01-012026-03-31RelatedPartyTransactionDomain475392682025-12-31RelatedPartyTransactionDomain475392682026-03-31RelatedPartyTransactionDomain475392682026-01-012026-03-31AuditorDomain1iso4217:INRiso4217:INRxbrli:shares539268SYNGENENOTLISTEDINE398R01022SYNGENE INTERNATIONAL LIMITEDMain BoardEquity2025-04-012026-03-312026-04-292026-04-15INRMillionsQuarterlyFourth quarterSingle segmentContract Research and Manufacturing Services2026-04-2910:00:002026-04-2916:10:00trueCash Flow IndirectDeclaration of unmodified opiniontruetrueYesYesfalsetrue2025-11-05https://cdn.syngeneintl.com/2025/11/06061039/Syngene-Policy-on-dealing-with-RPT-Nov-2025.pdffalsefalseThere has been no default on loans and debt securities.2026-01-012026-03-31AuditedStandalone960000000021600000098160000002022000000098000000248500000065000000953000000215200000077750000002041000000-7400000019670000003370000001480000004850000000148200000000001482000000-10240000004580000004029000000103.683.68003.683.682025-04-012026-03-31AuditedStandalone34238000000669000000349070000008243000000074000000904500000026000000038710000008730000000302230000004684000000-73200000039520000006810000002220000009030000000304900000000003049000000-2315000000734000000402900000010430090000007.587.57007.587.57Other Expenses1925000000Foreign exchange fluctuation loss/ (gain), net227000000Other Expenses8087000000Foreign exchange fluctuation loss/ (gain), net6430000002244000000053590000003150000000211500000053000000001118900000000330000000014489000000842000000125300000046866000000136900000044460000004325000000120500000060340000000373000000163830000000101000000018762000000656280000004029000000430090000004703800000047038000000022450000002245000000177000000197900000044010000000500000000260000000031000000002208000000530800000077050000001005000000171000000141890000001859000000065628000000Derivative assets317000000Other non-current financial assets2983000000Income tax assests (net)1130000000Other non-current assets123000000Derivative assets69000000Other current financial assets304000000Other current assets1010000000Lease liabilities1756000000Derivative liabilities488000000Other non-current financial liabilities1000000Other non-current liabilities1979000000Lease liabilities252000000Derivative liabilities1089000000Other current financial liabilities867000000Other current liabilities77050000000135000000-2020000000-110900000000001831000000000387100000002910000000005800000000334000000000000520900000091610000000568000000260000000442000000-101000000831000000000035000000000002638000000000235000000000000000000004800000000-5410000000-78380000000040000000000009170000002680000005040000009300000000-1778000000-1306000000176000000-113000000023350000001205000000Items that will not be reclassified to profit or loss1100000011000000Items that will not be reclassified to profit or loss-53000000-530000003000000-13000000Items that will be reclassified to profit or loss-1340000000-1340000000Items that will be reclassified to profit or loss-3027000000-3027000000-308000000-752000000-1024000000-2315000000Syngene International Limited******Abergy INC******Enterprise in which a Director of the Company is a member of the Board of DirectorsSale of goods or services150000000No remarks by the Audit Committee 637600001450000047870000Syngene International Limited******Bicara Therapeutics Inc.******Enterprise in which a Director of the Company is a member of the Board of DirectorsSale of goods or services1687000000No remarks by the Audit Committee 1052820000-445290000133640000Syngene International Limited******Biocon Biologics Limited******Fellow subsidiarySale of goods or services36000000No remarks by the Audit Committee 1007000013711000031320000Syngene International Limited******Biocon Biologics UK Limited******Fellow subsidiarySale of goods or services83000000No remarks by the Audit Committee 40060000498000010070000Syngene International Limited******Biocon Limited******Holding CompanySale of goods or services20000000No remarks by the Audit Committee 7700000399000021000000Syngene International Limited******Biocon Pharma Limited******Fellow subsidiarySale of goods or services43000000No remarks by the Audit Committee 63900003400005920000Syngene International Limited******Biocon SDN BHD******Fellow subsidiarySale of goods or services7000000No remarks by the Audit Committee 000Syngene International Limited******Biosimilar collaborations Ireland******Fellow subsidiarySale of goods or services4000000No remarks by the Audit Committee 000Syngene International Limited******BIOSIMILARS NEWCO LIMITED******Fellow subsidiarySale of goods or services15000000No remarks by the Audit Committee 30200001400001000000Syngene International Limited******Cage Therapeutics Incorporation******Enterprise in which a Director of the Company is a member of the Board of DirectorsSale of goods or services5910000No remarks by the Audit Committee 000Syngene International Limited******Immuneel Therapeutics Private Limited******Enterprise in which a Director of the Company is a member of the Board of DirectorsSale of goods or services21000000No remarks by the Audit Committee 643000078700007180000Syngene International Limited******Narayana Hrudayalaya Limited******Enterprise in which a Director of the Company is a member of the Board of DirectorsSale of goods or services10000000No remarks by the Audit Committee 000Syngene International Limited******Syngene Scientific solutions Ltd.******Wholly Owned SubsidiarySale of goods or servicesNo remarks by the Audit Committee 797700006800000032000000Syngene International Limited******Therapoma Inc******Enterprise in which a Director of the Company is a member of the Board of DirectorsSale of goods or services6000000No remarks by the Audit Committee 19200002400001000000Syngene International Limited******Third Arc Bio******Enterprise in which a Director of the Company has significant influenceSale of goods or services400000000No remarks by the Audit Committee 23024000090530000124410000Syngene International Limited******Syngene USA Inc.******Wholly Owned SubsidiarySale of goods or servicesNo remarks by the Audit Committee 2449000000Syngene International Limited******Puretech Health, USA******Enterprise in which a Director of the Company is a member of the Board of DirectorsSale of goods or services9000000No remarks by the Audit Committee 60600000-20030000Syngene International Limited******Biocon Biologics Limited******Fellow subsidiarySale of goods or services370000000No remarks by the Audit Committee 17161000000Syngene International Limited******Syngene Manufacturing solutions Ltd.******Wholly Owned SubsidiarySale of goods or servicesNo remarks by the Audit Committee 4000000Syngene International Limited******Syngene Scientific solutions Ltd.******Wholly Owned SubsidiarySale of goods or servicesNo remarks by the Audit Committee 4000000Syngene International Limited******Biocon Biologics Limited******Fellow subsidiarySale of goods or services100000000No remarks by the Audit Committee 2783000000Syngene International Limited******Biocon Limited******Holding CompanyAny other transactionExpenses reimbursement receivable10000000No remarks by the Audit Committee 000Syngene International Limited******Syngene Scientific solutions Ltd.******Wholly Owned SubsidiaryAny other transactionExpenses reimbursement receivableNo remarks by the Audit Committee 11921000000Syngene International Limited******Syngene USA Inc.******Wholly Owned SubsidiaryAny other transactionExpenses reimbursement receivableNo remarks by the Audit Committee 4758000020134000051830000Syngene International Limited******Therapoma Inc******Enterprise in which a Director of the Company is a member of the Board of DirectorsAny other transactionPurchase of goods12000000No remarks by the Audit Committee 000Syngene International Limited******Biocon Limited******Holding CompanyAny other transactionRent and facility services10000000No remarks by the Audit Committee 000Syngene International Limited******Biocon Biologics Limited******Fellow subsidiaryAny other transactionExpenses reimbursement receivable15000000No remarks by the Audit Committee 283000000Syngene International Limited******Syngene Scientific solutions Ltd.******Wholly Owned SubsidiaryAny other transactionRemittance of trade receivable realizedNo remarks by the Audit Committee 0-165010000-71240000Syngene International Limited******Syngene Scientific solutions Ltd.******Wholly Owned SubsidiaryAny other transactionPurchase of goods and servicesNo remarks by the Audit Committee 33519000000Syngene International Limited******Syngene Scientific solutions Ltd.******Wholly Owned SubsidiaryAny other transactionPurchase of goods and servicesNo remarks by the Audit Committee 823000000Syngene International Limited******Biocon Limited******Holding CompanyAny other transactionExpenses reimbursement payable333040000No remarks by the Audit Committee 133520000-102460000-53000000Syngene International Limited******Biocon Limited******Holding CompanyPurchase of goods or services200950000No remarks by the Audit Committee 8056000000Syngene International Limited******Biocon Biologics Limited******Fellow subsidiaryPurchase of goods or services159000000No remarks by the Audit Committee 4550000-46000000-5660000Syngene International Limited******Biocon Pharma Limited******Fellow subsidiaryAny other transactionExpenses reimbursement payable10000000No remarks by the Audit Committee 000Syngene International Limited******Immuneel Therapeutics Pvt Ltd.******Enterprise in which a Director of the Company is a member of the Board of DirectorsAny other transactionExpenses reimbursement payable10000000No remarks by the Audit Committee 000Syngene International Limited******Biocon Biologics Limited******Fellow subsidiaryPurchase of goods or services10000000No remarks by the Audit Committee 000Syngene International Limited******Biocon Limited******Holding CompanyPurchase of goods or services111000000No remarks by the Audit Committee 4964000000Syngene International Limited******Biocon Academy******Fellow subsidiaryAny other transactionCSR31000000No remarks by the Audit Committee 11950000-1200000Syngene International Limited******Biocon Academy******Fellow subsidiaryAny other transactionOtherNo remarks by the Audit Committee 004000000Syngene International Limited******Biocon Foundation******Trust in which a director is a trusteeAny other transactionCSR110000000No remarks by the Audit Committee 3825000004000000Syngene International Limited******Syngene USA Inc.******Wholly Owned SubsidiaryPurchase of goods or servicesNo remarks by the Audit Committee 495000000-157070000-44310000Syngene International Limited******Narayana Hrudayalaya Limited******Enterprise in which a Director of the Company is a member of the Board of DirectorsPurchase of goods or services10000000No remarks by the Audit Committee 4070000-40000-9490000Syngene International Limited******SOTC Travel Limited******Enterprise in which a Director of the Company is a member of the Board of Directors of Holding CompanyPurchase of goods or services170000000No remarks by the Audit Committee 64060000-7860000-12000000Syngene International Limited******Thomas Cook (India) Limited******Enterprise in which a Director of the Company is a member of the Board of DirectorsPurchase of goods or services10000000No remarks by the Audit Committee 000Syngene International Limited******Jeeves******Enterprise in which a member of the Promoter Group is a PartnerAny other transactionLaundry service7000000No remarks by the Audit Committee 2450000-1300000Syngene International Limited******Kiran Mazumdar Shaw******Non-Executive ChairpersonAny other transactionSitting fees & Commission10000000No remarks by the Audit Committee 255000000Syngene International Limited******Professor Catherine Rosenberg******Non-Executive DirectorAny other transactionSitting fees & Commission9000000No remarks by the Audit Committee 2780000003134670000AuditedtrueBSR & Co. LLPtrue2028-07-31